Additional Details

  • Nucleoside Therapy in Patients With Telomere Biology Disorders

    Boston Childrens Hospital
    Boston MA. 02115
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    AdventHealth Orlando
    Orlando FL. 32803
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Alabama at Birmingham
    Birmingham AL. 35205
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    National Jewish Health
    Denver CO. 80206
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Minnesota
    Minneapolis MN. 55455
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Kentucky
    Lexington KY. 40536
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Michigan - Michigan Medicine
    Ann Arbor MI. 48109-5360
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute
    Phoenix AZ. 85013
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    CHI Health Creighton University Medical Center - Bergan Mercy
    Omaha NE. 68124
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    University of Illinois Health
    Chicago IL. 60612
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Baylor University Medical Center
    Dallas TX. 75246
    View Details
  • Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

    Indiana University Health Methodist Hospital
    Indianapolis IN. 46202
    View Details
  • Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

    Snyder Building 480 Ray C. Hunt Drive
    Charlottesville VA. 22908
    View Details
  • NAL ER IPF Respiratory Function and Safety Study

    Mayo Clinic
    Rochester MN. 55905
    View Details
  • Inspiratory Work of Breathing Before and After Extubation

    Toronto General Hospital, University Health Network
    Toronto ON. M5G2C4
    View Details
  • Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

    Weill Cornell Medicine
    New York NY. 10065
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Trois-Rivières, Quebec
    Trois-Rivières QC. G8T 7A1
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Kansas City, KS
    Kansas City KS. 66160
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Dallas, TX
    Dallas TX. 75204
    View Details
  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Oklahoma City, OK
    Oklahoma City OK. 73104
    View Details